Innovation

Novel Compounds to Enhance Liver Repair & Regeneration (BIDMC 1259)

Beth Israel Deaconess Medical Center
posted on 12/18/2011

A novel non-small-cell lung cancer (NSCLC) cell line harboring the exon 20 A763_Y764insFQEA
epidermal growth factor receptor (EGFR) gene mutation. Cells were established using malignant pleural fluid from a
patient with stage IV NSCLC.


Innovation Details
 

File Number: 801 

Other Information:

Investigator(s)
MD Seth Karp

Contact
Catherine, Lenich M


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact Abi Barrow at Beth Israel Deaconess Medical Center for more information.

Request more info via email request more info
People

Case Manager:

Abi Barrow Abi Barrow

Innovations (0)

Download Technology Brief (PDF)


[?]
Followed By

Follow this innovation



No one is following this innovation.

Organization
3428

Beth Israel Deaconess Medical Center


Communities
Profile
Related Tags

Find more innovations

February 11, 2009

8,771 members 16,654 innovations 159 organizations

Browse

Scott Steele, coordinator of the CTSA-IP initiative and director of research alliances at the University of Rochester

"With more than 3,700 innovations from CTSA member institutions already on the iBridge Network, we're garnering worldwide exposure for the breakthroughs our researchers are accomplishing while moving toward our goal of increasing human health through clinical and translational research."  read more...